Web Stats Provided By Google Analytics

Thursday, March 6, 2014

Profectus BioSciences Chooses ABL for Preclinical Efficacy Studies

According to a release, selected regimens will be tested using an SIV infection model.

http://ift.tt/1gWPRe8
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)